fesoterodine,
fesoterodine fumarate,
toviaz,
Fesoterodine fumarate,
286930-03-8,
Toviaz,
SPM 907,
UNII-EOS72165S7,
SPM 8272,
SPM-907,
EOS72165S7,
SPM-8272,
Fesoterodine maleate,
2-((1R)-3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate,
2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl 2-methylpropanoate hydrogen (2E)-butenedioate (salt),
Propanoic acid, 2-methyl-, 2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl ester, (2E)-2-butenedioate (1:1) (salt),
Fesoterodine fumarate [USAN],
C26H37NO3.C4H4O4,
Fesoterodine fumarate [USAN:JAN],
Fesoterodinefumarate,
Toviaz (TN),
Fesoterodine fumarate/,
fesoterodine; fumaric acid,
Fesoterodine-fumarate-Toviaz,
Fesoterodine fumarate, Toviaz,
MLS003915638,
SCHEMBL814971,
Fesoterodine fumarate - Toviaz,
SCHEMBL1993632,
CHEMBL1201765,
Fesoterodine fumarate (JAN/USP),
MWHXMIASLKXGBU-RNCYCKTQSA-N,
BCPP000231,
(E)-but-2-enedioic acid,[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate,
HY-A0030,
ABP000771,
AN-490,
MFCD12756004,
s2240,
AKOS005146248,
AKOS015855886,
AC-3486,
BCP9000682,
CS-0822,
Fesoterodine fumarate|286930-03-8,
KS-1298,
SB19323,
AT-36463,
BC244477,
SMR002544691,
LS-184117,
X5023,
PF-00695838,
D08923,
930F038,
(E)-but-2-enedioic acid;[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate,
[2-[(1R)-3-(diisopropylamino)-1-phenyl-propyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate; fumaric acid,
Fesoterodinefumarate;(R)-Fesoterodine Fumarate;2-Methylpropanoic Acid 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl Ester (2E)-2-Butenedioate,
Propanoic acid, 2-methyl-, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl ester, (2E)-2-butenedioate (1:1),
Fesoterodine,
(R)-Fesoterodine fumarate,
cc-121,
CID9849808,
CID 9849808,
C26-H37-N-O3.C4-H4-O4,
B1618,
A10386,